REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Rella Pharma Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Rella Pharma Cia.Ltda Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Rella Pharma Cia.Ltda is an enterprise based in Ecuador. Its main office is in Cuenca. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on August 25, 2021. It currently has a total number of 4 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 58.21% in 2023. Its total assets grew by 55.9% over the same period. The net profit margin of Rella Pharma Cia.Ltda decreased by 16.54% in 2023.

Headquarters
Via a Buenos Aires
Cuenca; Azuay;

Contact Details: Purchase the Rella Pharma Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Rella Pharma Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Rella Pharma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Rella Pharma Cia.Ltda report to view the information.
Incorporation Date:
August 25, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Rella Pharma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
58.21%▲
Total operating revenue
58.21%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-94.95%▼
Total assets
55.9%▲
Total equity
-63.27%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-16.54%▼
Return on Equity (ROE)
-41.77%▼
Quick Ratio
-0.89%▼
Cash Ratio
0.07%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo